Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity

Neurobiology of Disease

Volumn 15, Issue 2, 2004, Pages 177-187

  Dzietko, Mark ^a   Felderhoff Mueser, Ursula ^a   Sifringer, Marco ^a   Krutz, Birte ^a   Bittigau, Petra ^a   Thor, Friederike ^b   Heumann, Rolf ^b   Bührer, Christoph ^a   Ikonomidou, Chrysanthy ^a   Hansen, Henrik H ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Akt; Apoptosis; Development; ERK; Erythropoietin; Neurodegeneration; Neuroprotection; Neurotrophin; NMDA receptor; Rat

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DIZOCILPINE; ERYTHROPOIETIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIN; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CLINICAL PRACTICE; CONTROLLED STUDY; FOREBRAIN; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIZOCILPINE MALEATE; ERYTHROPOIETIN; EXCITATORY AMINO ACID ANTAGONISTS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 10744222516     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.10.006     Document Type: Article

References (49)

1. Abernethy L.J., Palaniappan M., Cooke R.W.I. Quantitative magnetic resonance imaging in the brain in survivors of very low birth weight. Arch. Dis. Child. 87:2002;279-283.
2. Ajayi-Obe M., Saeed N., Cowan F.M., Rutherford M.A., Edwards A.D. Reduced development of cerebral cortex in extremely preterm infants. Lancet. 356:2000;1162-1163.
3. Alafaci C., Salpietro F., Grasso G., Sfacteria A., Passalacqua M., Morabito A., Tripodo E., Calapai G., Buemi M., Tomasello F. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur. J. Pharmacol. 406:2000;219-225.
4. Allan L.A., Morrice N., Brady S., Magee G., Pathak S., Clarke P.R. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat. Cell Biol. 5:2003;647-654.
5. Bittigau P., Sifringer M., Genz K., Reith E., Pospischil D., Govindarajalu S., Dzietko M., Pesditschek S., Mai I., Dikranian K., Olney J.W., Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl. Acad. Sci. U. S. A. 99:2002;15089-15094.
6. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10526-10531.
7. Buemi M., Allegra A., Corica F., Floccari F., D'Avella D., Aloisi C., Calapai G., Iacopino G., Frisina N. Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. Nephrol. Dial. Transplant. 15:2000;422-423.
8. Chong Z.Z., Kang J.Q., Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation. 106:2002;2973-2979.
9. Dame C., Juul S.E., Christensen R.D. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol. Neonate. 79:2001;228-235.
10. DeOlmos J.S., Ingram W.R. An improved cupric-silver method for impregnation of axonal and terminal degeneration. Brain Res. 33:1971;523-529.
11. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature. 412:2001;641-647.
12. Digicaylioglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3717-3720.
13. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum. Dev. 3:1979;79-83.
14. Gorio A., Gokmen N., Erbayraktar S., Yilmaz O., Madaschi L., Cichetti C., Di Giulio A.M., Vardar E., Cerami A., Brines M. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. U. S. A. 99:2002;9450-9455.
15. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M., Reme C.E. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8:2002;718-724.
16. Hack M., Flannery D.J., Schluchter M., Cartar L., Borawski E., Klein N. Outcomes in young adulthood for very-low-birth-weight infants. N. Engl. J. Med. 348:2002;149-157.
17. Hardingham G.E., Bading H. The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 26:2003;81-89.
18. Heumann R. Neurotrophin signalling. Curr. Opin. Neurobiol. 4:1994;668-679.
19. Heumann R., Goemans C., Bartsch D., Lingenhöhl K., Waldmeier P.C., Hengerer B., Allegrini P.R., Schellander K., Wagner E.F., Arendt T., Kamdem R.H., Obst-Pernberg K., Narz F., Wahle P., Berns H. Transgenic activation of ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J. Cell Biol. 151:2000;1537-1548.
20. Huang E.J., Reichardt L. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24:2001;677-736.
21. Ikonomidou C., Bosch F., Miksa M., Vöckler J., Bittigau P., Dikranian K., Tenkova T., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
22. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., Price M.T., Stefovska V., Hörster F., Tenkova T., Dikranian K., Olney J.W. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 287:2000;1056-1060.
23. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., Zorumski C.F., Olney J.W., Wozniak D.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 23:2003;876-882.
24. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10659-10664.
25. Juul S.E., Harcum J., Li Y., Christensen R.D. Erythropoietin is present in the cerebrospinal fluid of neonates. J. Pediatr. 130:1997;428-430.
26. Juul S.E., Anderson D.K., Li Y., Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 43:1998;40-49.
27. Juul S.E., Stallings S.A., Christensen R.D. Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr. Res. 46:1999;543-547.
28. Juul S.E., Yachnis A.T., Rojiani A.M., Christensen R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr. Dev. Pathol. 2:1999;148-158.
29. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10:2000;381-391.
30. Klingmüller U., Lorenz U., Cantley L.C., Neel B.C., Lodish H.C. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
31. Koehne P., Hochhaus F., Felderhoff-Mueser U., Ring-Mrozik E., Obladen M., Bührer C. Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus. Child's Nerv. Syst. 18:2002;137-141.
32. Kumral A., Ozer E., Yilmaz O., Akhisaroglu M., Gokmen N., Duman N., Ulukus C., Genc S., Ozkan H. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol. Neonate. 83:2003;224-228.
33. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science. 294:2001;1945-1948.
34. Levin I., Cohen J., Supino-Rosin L., Yoshimura A., Watowich S.S., Neumann D. Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization. FEBS Lett. 427:1998;164-170.
35. Liu C., Shen K., Liu Z., Noguchi C.T. Regulated human erythropoietin receptor expression in mouse brain. J. Biol. Chem. 272:1999;32395-32400.
36. Marti H.H., Wenger R.H., Rivas L.A., Straumann U., Digicaylioglu M., Henn V., Yonekawa Y., Bauer C., Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8:1996;666-676.
37. Marti H.H., Gassmann M., Wenger R.H., Kvietikova I., Morganti-Kossmann M.C., Kossmann T., Trentz O., Bauer C. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int. 51:1997;416-418.
38. Masuda S., Okano S., Yamagishi M., Nagao K., Ueda M., Sasaki M. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269:1994;19488-19493.
39. Ment L.R., Vohr B., Allan W., Katz K.H., Schneider K.C., Westerveld M., Duncan C.C., Makuch R.W. Change in cognitive function over time in very-low-birth-weight infants. JAMA. 289:2003;705-711.
40. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 76:1997;105-116.
41. Murphy D.J., Sellers S., MacKenzie I.Z., Yudkin P.L., Johnson A.M. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 346:1995;1449-1454.
42. Nosarti C., Al-Asady M.H.S., Frangou S., Stewart A.L., Rifkin L., Murray R.-M. Adolescents who were born very preterm have decreased brain volumes. Brain. 125:2002;1616-1623.
43. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4635-4640.
44. Setchenska M.S., Bonanou-Tzedaki H.R., Arnstein S.A. The effect of erythropoietin on the adenylate cyclase activity of rabbit bone marrow erythroblasts. Biomed. Biochim. Acta. 46:1987;S146-S150.
45. Sirén A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4044-4049.
46. Taylor D.L., Edwards D., Mehmet H. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol. 9:1999;93-117.
47. Thiel S., Sommer U., Kortylewski M., Haan C., Behrmann I., Heinrich P.C., Graeve L. Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis. FEBS Lett. 470:2000;15-19.
48. Vohr B.R., Wright L.L., Dusick A.M., Mele L., Verter J., Steichen J.J., Simon N.P., Wilson D.C., Broyles S., Bauer C.R., Delaney-Black V., Yolton K.A., Fleisher B.E., Papile L.A., Kaplan M.D. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics. 105:2000;1216-1226.
49. West M.J., Gundersen H.J.G. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. Comp. Neurol. 296:1990;1-22.